Interferon Gamma study on Friedreich’s Ataxia in the US

Interferon Gamma study on Friedreich’s Ataxia in the US, did not meet it's requirements in a recent phase III study; Horizon Pharma have recently announced. This may mean research will have to shift focus elsewhere but fortunately there are other possible therapeutic candidates with potential benefit to people with FA. See the link below for press release issued from Horizon.

http://ir.horizon-pharma.com/releasedetail.cfm?ReleaseID=1003338

Follow Ataxia Ireland on Facebook Follow Ataxia Ireland on Twitter

Monthly Lottery sign up button


Text "ATAXIA" to 50300 to donate €4 now! »

People living with an Ataxia benefit enormously from the many services provided by Ataxia Ireland.
Help us to continue helping them


Donate to Ataxia »

Donate to FASILend a helping hand...
Donate to FASI

Ataxia Organsiations »

Click to view European Ataxia OrganisationsClick on the map to access an interactive map for Ataxia organisations worldwide

Follow Ataxia Ireland